-
CureDuchenne Hosts “Champions in Miami” Event on March 9 to Help Find a Cure for Duchenne Muscular Dystrophy
DJ Irie of the Miami Heat Headlines as Event Brings Together Miami’s Top Business Leaders,
-
Edgewise Therapeutics’ EDG-5506 on FDA fast track for Duchenne MD
EDG-5506, an oral treatment being developed by Edgewise Therapeutics, has been granted fast track designation
-
WATCH: PTC Therapeutics — EMFLAZA® Landscape in 2024 (Webinar Recording)
PPMD was recently joined by the team at PTC Therapeutics to discuss upcoming changes and
-
Cognitive abilities stable over time in Becker MD boys, study finds
Cognitive function in boys with Becker muscular dystrophy (BMD) appear to be stable over time,
-
PPMD Provides $500,000 in Funding to Kinea Bio Through PPMD Venture Pathways Program to Support Next-Gen Midi-Dystrophin Gene Therapy Development
PPMD is excited to announce that the organization has provided $500,000 in funding to Kinea
-
MDA advocacy program awards $140K to 7 rare disease groups
With projects spanning gene therapy research, patient advocacy, and air travel safety, seven U.S. organizations
-
When I get overwhelmed by life as a caregiver, I count my joys
Pulling into a parking spot at my oldest son’s high school, I hit a parked
-
Finding the Right One: Advice from Experts on Dating with a Disability
“So, are you dating anyone?” Could there possibly be five more scary words spoken to
-
Update From PPMD’s 2024 PPMD Duchenne Healthcare Professionals Summit
PPMD recently hosted our fifth in-person Duchenne Healthcare Professionals Summit in Sanibel, FL. Over the
-
Watch: Dyne Therapeutics — Advancing DYNE-251, an Investigational Medicine for DMD (Webinar Recording)
Dyne Therapeutics recently joined PPMD for a community webinar to present initial clinical data from
